NCT04714983 2024-04-09DNX-2440 for Resectable Colorectal Liver MetastasisDNAtrix, Inc.Phase 1 Suspended30 enrolled
NCT00623831 2022-10-25A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 AntigenLudwig Institute for Cancer ResearchPhase 1 Completed17 enrolled 14 charts
NCT00031681 2013-09-307-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)National Cancer Institute (NCI)Phase 1 Completed41 enrolled
NCT00010023 2011-04-05Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsNYU Langone HealthPhase 1 Completed
NCT00049296 2010-06-11Thalidomide and Docetaxel in Treating Patients With Advanced CancerCase Comprehensive Cancer CenterPhase 1 Completed26 enrolled